Brief: Pacira Biosciences Q3 Revenue USD 179.5 Million Vs. IBES Estimate USD 182.9 Million
06/11/2025 21:01
Nov 06 (Reuters) - Pacira Biosciences Q3 adjusted net income USD 31.8 million vs. IBES estimate USD 31.8 million. Q3 net income USD 5.4 million Q3 cash & investments USD 246.3 million Q3 adjusted EBITDA USD 49.4 million vs. IBES estimate USD 46.5 million
Recent news on Pacira BioSciences
See all newsUS STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal